foxo4-dri human trial The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound foxo4-dri human trials improves spermatogenesis
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





















